• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Pacira Pharmaceuticals Inc/DE

+ Add to Watchlist

PCRX:US

66.0500 USD 1.6700 2.47%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Pacira Pharmaceuticals Inc/DE (PCRX)

Open: 67.1200 Day's Range: 65.2800 - 68.9000 Volume: 185,120
Previous Close: 67.7200 52wk Range: 24.7000 - 83.4100 1-Yr Rtn: +131.19%

Stock Chart for PCRX

No chart data available.
  • PCRX:US 66.0500
  • 1D
  • 1M
  • 1Y
67.7200
Interactive PCRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PCRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8625
Est. EPS (USD) (12/2014) -0.1170
Est. PEG Ratio -
Market Cap (M USD) 2,226.81
Shares Outstanding (M) 33.71
30 Day Average Volume 538,533
Price/Book (mrq) 53.8604
Price/Sale (ttm) 25.7080
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PCRX

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.

David M Stack "Dave"Chairman/CEOJames S ScibettaChief Financial Officer
Taunia MarkvickaVP:CommercialLauren RikerExec Director:Accounting
More Company Profile & Key Executives for PCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil